Skip to main content

News & Events

September 22, 2026 in News

Aranscia Announces Molecular Laboratory Integration Initiative with Northside Hospital to Advance Precision Oncology

Aranscia Announces Molecular Laboratory Integration Initiative with Northside Hospital to Advance Precision Oncology Initiative integrates Aranscia’s 2bPrecise and Spesana platforms with leading molecular laboratories to streamline genomic testing across Northside’s…
Read More
July 28, 2026 in News, Pharmacogenomic, Webinars

Dr. Joel Diamond Featured on Healthcare de Jure Podcast

Host Matt Fisher talks to Dr. Joel Diamond, Chief Medical Officer at Aranscia, about defining genetics, genomics, and molecular testing; switching treatment from body area to specific genetic makeup; the…
Read More
June 30, 2026 in News

InterVenn Biosciences And Aranscia Expand Commercialization Partnership For GlycoKnow™ Ovarian Cancer Diagnostic Test

Aranscia’s Technology Platform to Accelerate InterVenn’s Research and Commercialization Initiatives SOUTH SAN FRANCISCO, Calif. and HOUSTON, June 30, 2026 /PRNewswire/ — InterVenn Biosciences, a life sciences company unlocking the value of…
Read More
January 7, 2026 in News

InterVenn Biosciences Partners With Aranscia To Accelerate Commercialization Of GlycoKnow™ Non-Invasive Ovarian Cancer Diagnostic Test

SOUTH SAN FRANCISCO & HOUSTON – January 7, 2026  InterVenn Biosciences, a precision diagnostics company advancing liquid biopsy with glycoproteomics, and Aranscia, a global provider of award-winning clinical workflow and diagnostic technology…
Read More
October 16, 2025 in News

DPYD Safety Update: Reducing The Risk Of Critical Or Fatal Chemotherapy Side Effects

Aranscia® solutions help oncologists comply with new FDA warning label requiring  DPYD genetic testing in patients receiving select chemotherapies HOUSTON, Oct. 16, 2025 /PRNewswire/ — Oncologists and pharmacy experts are reacting to last…
Read More
June 26, 2025 in News

Spartanburg Regional Healthcare System (SRHS) Deploys 2bPrecise Enterprise

Multi-year partnership affirms SHRS as a leader in precision care and genomics SPARTANBURG, S.C. and HOUSTON, June 25, 2025 /PRNewswire/ — Spartanburg Regional Healthcare System (SRHS) today announced its deployment of the 2bPrecise® enterprise platform. Under this…
Read More